广济药业
(000952)
| 流通市值：17.51亿 | | | 总市值：18.01亿 |
| 流通股本：3.44亿 | | | 总股本：3.54亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 545,130,013.77 | 1,037,796,985.16 | 391,957,692.53 | 431,353,466.65 |
| 应收票据及应收账款 | 228,668,631.81 | 242,330,515.37 | 168,438,472.56 | 201,950,934.45 |
| 应收账款 | 228,668,631.81 | 242,330,515.37 | 168,438,472.56 | 201,950,934.45 |
| 应收款项融资 | 40,513,528.52 | 36,061,574.87 | 86,578,079.82 | 92,668,376.65 |
| 预付款项 | 63,795,781.08 | 73,145,109.29 | 49,198,037.75 | 37,710,781.63 |
| 其他应收款合计 | 9,154,406.16 | 30,654,944.55 | 10,484,882.76 | 7,607,906.36 |
| 存货 | 308,679,509.33 | 313,405,809.34 | 262,238,899.19 | 221,470,974 |
| 其他流动资产 | 14,461,303.4 | 13,641,103.64 | 11,942,510.54 | 12,732,978.4 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,210,403,174.07 | 1,747,036,042.22 | 980,838,575.15 | 1,005,495,418.14 |
| 非流动资产: | | | | |
| 长期股权投资 | 29,861,617.1 | 31,756,767.35 | 33,864,153.83 | 36,851,202.77 |
| 其他权益工具投资 | 7,280,000 | 7,280,000 | 7,280,000 | 7,280,000 |
| 固定资产 | 1,156,161,656.28 | 1,175,899,977.4 | 915,499,752.26 | 936,717,237.72 |
| 在建工程 | 88,604,464.07 | 72,674,822.31 | 292,585,714.9 | 258,138,228.29 |
| 使用权资产 | 3,505,028.43 | 3,752,125.95 | 4,080,555.19 | 4,327,652.71 |
| 无形资产 | 147,420,702.18 | 148,470,575.83 | 149,540,517.79 | 150,616,268.4 |
| 开发支出 | 292,558.07 | - | - | - |
| 长期待摊费用 | 690,922 | 690,922 | 719,137.24 | 578,956.25 |
| 递延所得税资产 | 30,143,535.05 | 28,342,397.2 | 27,244,800.51 | 26,798,192.16 |
| 其他非流动资产 | 503,690,427.02 | 29,445,272.28 | 47,898,371.57 | 42,250,791.4 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,967,650,910.2 | 1,498,312,860.32 | 1,478,713,003.29 | 1,463,558,529.7 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,178,054,084.27 | 3,245,348,902.54 | 2,459,551,578.44 | 2,469,053,947.84 |
| 流动负债: | | | | |
| 短期借款 | 196,000,000 | 262,000,000 | 269,000,000 | 197,125,833.33 |
| 应付票据及应付账款 | 128,868,284.12 | 143,658,406.59 | 96,177,311.68 | 178,597,322.3 |
| 其中：应付票据 | - | - | 2,300,000 | 61,420,000 |
| 应付账款 | 128,868,284.12 | 143,658,406.59 | 93,877,311.68 | 117,177,322.3 |
| 合同负债 | 7,113,686.37 | 4,980,049.18 | 11,407,042.28 | 5,491,563.8 |
| 应付职工薪酬 | 20,559,335.92 | 17,178,078.81 | 16,378,995.14 | 16,449,203.79 |
| 应交税费 | 14,209,933.43 | 8,386,372.83 | 9,383,422.36 | 17,643,323.3 |
| 其他应付款合计 | 90,094,357.71 | 72,454,359.16 | 84,999,380.06 | 78,298,494.4 |
| 应付股利 | 3,767,826.9 | 3,767,826.9 | 3,767,826.9 | 3,767,826.9 |
| 一年内到期的非流动负债 | 295,625,983.79 | 302,184,737.25 | 279,704,994.22 | 160,116,874.62 |
| 其他流动负债 | 90,263,441.03 | 90,388,420.3 | 846,744.55 | 311,610.53 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 842,735,022.37 | 901,230,424.12 | 767,897,890.29 | 654,034,226.07 |
| 非流动负债: | | | | |
| 长期借款 | 469,265,000 | 467,365,000 | 109,450,000 | 244,950,000 |
| 租赁负债 | 2,450,933.29 | 2,680,489.95 | 3,110,761.52 | 3,192,788.34 |
| 长期应付款 | 363,935,131.57 | 385,812,624.79 | 111,000,000 | 56,614,900 |
| 预计负债 | 335,026.85 | 335,026.85 | 335,026.85 | 335,026.85 |
| 递延收益 | 16,242,237.63 | 16,830,358.3 | 17,389,907.59 | 18,120,885.4 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 852,228,329.34 | 873,023,499.89 | 241,285,695.96 | 323,213,600.59 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,694,963,351.71 | 1,774,253,924.01 | 1,009,183,586.25 | 977,247,826.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 353,973,939 | 353,973,939 | 353,973,939 | 353,973,939 |
| 资本公积 | 402,158,597.8 | 398,483,180.26 | 395,043,365.24 | 391,085,898.41 |
| 减:库存股 | 36,189,810 | 36,189,810 | 36,189,810 | 36,189,810 |
| 其他综合收益 | -18,572.99 | -7,404.46 | -22,028.28 | -24,764.99 |
| 盈余公积 | 149,209,540.72 | 149,209,540.72 | 149,209,540.72 | 149,209,540.72 |
| 未分配利润 | 577,605,611.75 | 618,777,242.41 | 600,543,239.78 | 644,581,781.63 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,446,739,306.28 | 1,484,246,687.93 | 1,462,558,246.46 | 1,502,636,584.77 |
| 少数股东权益 | 36,351,426.28 | -13,151,709.4 | -12,190,254.27 | -10,830,463.59 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,483,090,732.56 | 1,471,094,978.53 | 1,450,367,992.19 | 1,491,806,121.18 |
| 负债和股东权益合计 | 3,178,054,084.27 | 3,245,348,902.54 | 2,459,551,578.44 | 2,469,053,947.84 |
| 公告日期 | 2023-10-21 | 2023-08-31 | 2023-04-28 | 2023-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |